Lepirudin in Treating Patients With Recurrent or Advanced Small Cell Lung Cancer

NCT00003726 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Study funding was dropped.

Conditions

Lung Cancer

Interventions

BIOLOGICAL: lepirudin

Sponsor

Dartmouth-Hitchcock Medical Center

Collaborators

[object Object]